Previous studies have shown that the increased expression of IL-22R was observed in various types of inflammation involving epithelial tissue and mucosal surfaces, such as inflammatory bowel disease (IBD), atopic dermatitis, and chronic obstructive pulmonary disease (COPD) [68]. This evidence concerns the gene IL22RA1 and atopic eczema.